Search results

Filter

Filetype

Your search for "*" yielded 126942 hits

New research track: higher amounts of dietary fibre before the age of two can reduce the later risk of coeliac disease

The results of an observational study from Lund University in Sweden are clear: up to the age of two, a more fibre-rich diet seems to reduce the risk of coeliac disease. A particularly clear link was seen when children had eaten fibre-rich foods before the age of one. “This is the first time the risk of coeliac disease has been studied based on fibre in children’s diets. But a clinical trial is al

https://www.ludc.lu.se/article/new-research-track-higher-amounts-dietary-fibre-age-two-can-reduce-later-risk-coeliac-disease - 2025-11-19

Hjelt Diabetes Foundation supports research that can pave the way for new cell therapies

Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. The Bo and Kerstin Hjelt Diabetes Foundation provides support to two diabetes researchers at Lund University Diabetes Centre who contribute with new knowledge to this research field. Type 1 diabetes is a condition wh

https://www.ludc.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-11-19

International islet cell researchers met at conference in Malmö

International researchers who study islets of Langerhans met for a conference in Malmö in June. Studies of insulin-producing cells help us understand disease mechanisms in diabetes. Lund University Diabetes Centre and the strategic research area EXODIAB hosted the event. Lund University Diabetes Centre (LUDC) and the strategic research are EXODIAB (Excellence of Diabetes Research in Sweden) hosted

https://www.ludc.lu.se/article/international-islet-cell-researchers-met-conference-malmo - 2025-11-19

Charlotte Ling receives major grant for clinical diabetes research

Congratulations to Charlotte Ling who, together with Katarina Fagher and Alice Maguolo, has been awarded a grant of five million Danish kroner by the Novo Nordisk Foundation. The funding will support clinical research in precision medicine, focusing on epigenetic analysis of blood samples from 13,000 individuals. Charlotte Ling, a professor in diabetes research with a particular focus on epigeneti

https://www.ludc.lu.se/article/charlotte-ling-receives-major-grant-clinical-diabetes-research - 2025-11-19

Biomarkers reveal risk of cardiovascular disease in type 2 diabetes

An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes are at risk of cardiovascular disease. The study is now published in Cell Reports Medicine. People with type 2 diabetes are up to four times more likely to have heart attacks, strokes, anginas and other coronary heart diseases than healthy people. Therefo

https://www.ludc.lu.se/article/biomarkers-reveal-risk-cardiovascular-disease-type-2-diabetes - 2025-11-19

Award for protein research that may lead to new treatments of diabetes

Inflammation researcher Ben King studies the function of two different proteins in connection with diabetes. In the future, such knowledge may be important for the development of new treatments for people with diabetes. Ben King is this year’s recipient of the Medeon Award for his innovative research. “I was very surprised and feel very honored to receive the award. In my role, I do a lot of exper

https://www.ludc.lu.se/article/award-protein-research-may-lead-new-treatments-diabetes - 2025-11-19

Six LUDC researchers receive medicine and health grants from VR

We would like to congratulate six researchers at Lund University Diabetes Centre, who have been awarded research grants within medicine and health by the Swedish Research Council (VR). The six researchers are affiliated with Excellence of Diabetes Research in Sweden (EXODIAB), which is a strategic research area within diabetes at Lund University.Helena Elding Larsson, professor of autoimmune disea

https://www.ludc.lu.se/article/six-ludc-researchers-receive-medicine-and-health-grants-vr - 2025-11-19

Oral insulin delayed onset of type 1 diabetes in some children with increased risk of the disease

An international team of researchers has investigated whether oral insulin can prevent early signs of type 1 diabetes and clinical diagnosis in children with an increased risk of developing the disease. Although treatment with oral insulin could not prevent development of diabetes-related autoantibodies, oral insulin delayed the rate of disease progression in children who developed such autoantibo

https://www.ludc.lu.se/article/oral-insulin-delayed-onset-type-1-diabetes-some-children-increased-risk-disease - 2025-11-19

Review: Type 2 diabetes and obesity – what do we really know?

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics and lifestyle factors. By studying how our genes express themselves in response

https://www.ludc.lu.se/article/review-type-2-diabetes-and-obesity-what-do-we-really-know - 2025-11-19

New research on classification of diabetes identifies high-risk group

Diabetes researchers at Lund University have previously shown that people with diabetes can be stratified into five subgroups with differing disease progression. A new study by the same researchers provides increased evidence for the clinical relevance of the classification system. The researchers also present new findings of significant differences between subgroups in the development of complica

https://www.ludc.lu.se/article/new-research-classification-diabetes-identifies-high-risk-group - 2025-11-19

Lund initiates genetic sequencing study in diabetes families to provide new insights into what causes the disease

Lund University Diabetes Centre has entered into a collaboration with the Regeneron Genetics Center LLC (RGC) and the University of Helsinki involving exome-sequencing and whole genome array genotyping of greater than 9,000 individuals. The collaboration will involve the largest sequencing study in diabetes families to date and aims to help generate knowledge about how to predict diabetes, causes

https://www.ludc.lu.se/article/lund-initiates-genetic-sequencing-study-diabetes-families-provide-new-insights-what-causes-disease - 2025-11-19

THADA - new findings in the role of the mother in type 2 diabetes

Research from Lund University in Sweden can explain why type 2 diabetes is inherited to a greater extent from an individual’s mother. The heredity of a previously known risk gene, THADA, has proven to be dominant if it comes from the mother, whereas it has little or no effect on the child’s risk of disease if it originates from the father.
“Our research contributes to increased knowledge about the

https://www.ludc.lu.se/article/thada-new-findings-role-mother-type-2-diabetes - 2025-11-19

New findings explain the connection between melatonin and type 2 diabetes

A new experimental and clinical study from Lund University in Sweden shows that the sleep hormone melatonin impairs insulin secretion in people with a common gene variant.

“This could explain why the risk of type 2 diabetes is greater among, for instance, overnight workers or people with sleeping disorders”, says Professor Hindrik Mulder who is responsible for the study. Melatonin is a naturally

https://www.ludc.lu.se/article/new-findings-explain-connection-between-melatonin-and-type-2-diabetes - 2025-11-19

New findings can lead to a new principle for treating diabetic kidney damage

One in three people with diabetes will face some form of renal impairment in the course of their lives. Studies conducted by researchers at the Lund University Diabetes Centre may lead to the development of an entirely new principle for treating type 2 diabetes and preventing kidney damage in the future. Previous analyses have not been able to identify genetic causes as to why some people have a h

https://www.ludc.lu.se/article/new-findings-can-lead-new-principle-treating-diabetic-kidney-damage - 2025-11-19

New findings can lead to a new principle for treating diabetic kidney damage

One in three people with diabetes will face some form of renal impairment in the course of their lives. Studies conducted by researchers at the Lund University Diabetes Centre may lead to the development of an entirely new principle for treating type 2 diabetes and preventing kidney damage in the future. Previous analyses have not been able to identify genetic causes as to why some people have a h

https://www.ludc.lu.se/article/new-findings-can-lead-new-principle-treating-diabetic-kidney-damage-0 - 2025-11-19

Focus on personalized treatment of type 2 diabetes and cardiovascular disease

The European Research Council makes a large investment in diabetes research. A project led by Professor Paul Franks at Lund University Diabetes Centre is to develop methods that can be used in the design of preventive treatment for type 2 diabetes and cardiovascular disease. - Through this project we will use functional genomics and epidemiology to identify novel molecular mechanisms that underlie

https://www.ludc.lu.se/article/focus-personalized-treatment-type-2-diabetes-and-cardiovascular-disease - 2025-11-19

Type 2 diabetes and obesity - what do we really know?

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund University, Sweden, examine the knowledge of the actual causes and the interplay between genetics and lifestyle factors. By studying how our genes express themselves in response

https://www.ludc.lu.se/article/type-2-diabetes-and-obesity-what-do-we-really-know - 2025-11-19

Konsthögskolan i Malmö anställer två nya doktorander

Från och med januari ansluter sig Jürgen Bock och Pia Rönicke till Konsthögskolans forskarutbildning i fri konst. Jürgen Bock är en internationellt betydande curator och konstnär som bland annat etablerat det välrenommerade utbildningsprogrammet Maumaus i Lissabon. Pia Rönicke är också hon en internationellt framstående konstnär och en av föregångarna inom researchbaserad konst.

https://www.khm.lu.se/artikel/konsthogskolan-i-malmo-anstaller-tva-nya-doktorander - 2025-11-19

Alumni Martine Tunhold blir assistent till Mary Kelly

Bildkonstnärsfonden har utsett 21 nya assistentstipendiater inom bild- och formområdet. Stipendierna är på 100 000 kronor och ger möjlighet att under fem till tio månader arbeta som assistent till en mer erfaren kollega. Bland stipendiaterna märks bland andra Martine Tunhold, alumn vid Konsthögskolan i Malmö, som kommer att assistera Mary Kelly i USA. Kelly är, förutom världsberömd konstnär, heder

https://www.khm.lu.se/artikel/alumni-martine-tunhold-blir-assistent-till-mary-kelly - 2025-11-19